-
Cancer Care Does Not Move in Straight Lines
Cathy Nobil-Dutton did all the right things to protect her health, but a uterine cancer diagnosis showed her life doesn’t always go as expected.
by Cathy Nobil-Dutton
-
May 31: The Week in Cancer News
Young adults often ignore telltale signs of colorectal cancer, and more evidence supports active surveillance for low-risk prostate cancer.
by Marci A. Landsmann
-
Regular Aspirin Use May Help Fight Colorectal Cancer
Aspirin appears to activate an immune response against colorectal cancer in the early stages of the disease.
by Sandra Gordon
-
May 24: The Week in Cancer News
New immunotherapy approved for small cell lung cancer, and researchers investigate using urine tests to detect cancer.
by Kevin McLaughlin
-
May 17: The Week in Cancer News
Disparities in cancer outcomes shrink but persist, and FDA approval increases access to HPV screening.
by Eric Fitzsimmons
-
Progress Against Cancer
New research fuels progress in cancer survival, prevention and side effect management.
-
May 10: The Week in Cancer News
People may be able to wait longer between colonoscopies, and a trial evaluates a less invasive option for treating prostate cancer.
by Thomas Celona
-
Experts Urge Consideration Before Switching Cancer Care Providers
Patients should consider the potential risks, and not just rewards, before changing providers.
by Kyle Bagenstose
-
May 3: The Week in Cancer News
Updated recommendation lowers age for breast cancer screening, and laboratory tests will undergo greater FDA oversight.
by Marci A. Landsmann
-
April 26: The Week in Cancer News
Supplemental breast screenings are not covered by Medicare, and researchers develop a treatment option for a form of eye cancer.
by Kevin McLaughlin
Cancer Talk
Screening Options for People With Dense Breasts
Reports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon